top of page

​BIOMANUFACTURING COSTS ARE TOO HIGH.
WE HELP BRING THEM DOWN.

Saku Biosciences is engineering host cell products that improve biomanufacturing economics 

heroCurve.png
heroCurve.png
heroCurve.png
heroCurve.png
7.jpg

ECONOMICS BEGIN WITH THE HOST CELL

Saku is focused on a single idea: when you improve the host cell, you improve the economics of everything that follows.
​
Today, most companies begin with research-grade cell lines that take five to ten years to become market-ready. But commercial timelines rarely allow for that. As a result, teams are often forced to move forward within roughly two years using suboptimal cells, locking in scale-up cost and complexity early.
​
Saku provides industry-ready cell lines designed to shorten cell line development and strain engineering timelines, accelerate time to market, and improve manufacturing economics from the start.
Image by National Cancer Institute
Saku PPT V2 (2).png

WE ARE ENGINEERING HOST CELLS THAT:

image (2).png
image (3).png
Saku PPT V2 (2).png
Saku PPT V2 (2)_edited.png

INCREASE TITERS

Higher output changes process economics.

  • More product per run

  • Shorter batch times to target yields

  • Lower media, time, and equipment intensity

USE ALTERNATIVE FEEDSTOCKS

Feedstocks improve supply chains and resilience.

  • Host cells adapted to regionally available inputs

  • Reduced dependence on single-source commodities

  • Unlock value from underutilized waste or side streams

REDUCE DOWNSTREAM COSTS

Upstream quality dictates downstream processing cost.

  • Reduced impurity load entering purification

  • Higher quality product

  • Lower downstream processing complexity and cost

5.jpg

HOW TO WORK WITH US

Host cell products are in development. Services are available today.

SAKU PRODUCTS

(IN DEVELOPMENT)

  • Host cells, chassis, and strains that improve manufacturing economics

  • Have a better starting point for scale-up

  • Supplies industry-ready cell lines and chassis

  • Easy-to-use genetic tooling

​SAKU SERVICES
​(NOW)

  • Targeted programs that improve titers in 1-3 months

  • Compresses cell engineering timelines from years to months

  • Mobile teams so that you don’t have to send your cell line or strain

  • You keep your IP, no revenue sharing or royalties

bottom of page